Recent ATLAS Results on Forward Physics and Diffraction

The ATLAS detector at the LHC is equipped with dedicated systems designed for the detection of forward protons produced in diffractive and photon-induced processes. These detectors significantly extend the ATLAS physics reach. Recent measurements performed using these forward proton detectors: elastic proton-proton scattering, exclusive charged pion-pair production, and two-photon production of lepton pairs are presented.Comment: 6 pages, 4 figure

Forward proton physics at LHC

Diffractive phenomena constitute a large fraction of interactions occurring in pp collisions at LHC. Because of the non-perturbative nature, their present understanding is still relatively poor and uncertain. One of the methods to study these processes is forward proton tagging. I will discuss the mechanism of diffractive processes, recent results, and potential implications. The proton tagging method can also be used for measurements of photon-induced processes, in particular, the photon-photon interactions. I will present the physics behind these processes, the experimental status and the lessons we can learn for the strong interactions and for the electroweak sector.Comment: Presented at DIS2023: XXX International Workshop on Deep-Inelastic Scattering and Related Subjects, Michigan State University, USA, 27-31 March 202

Wartość dla pacjenta – budowa strategii optymalizacji terapii chorób reumatycznych z perspektywy pacjenta, lekarza i firmy farmaceutycznej

Model opieki medycznej skoncentrowany na pacjencie stanowi jedno z podejść często uwzględnianych w badaniach naukowych. Celem pracy było przedstawienie ewolucji systemów opieki zdrowotnej w kierunku traktowania pacjenta jako najważniejszego i ostatecznego beneficjenta. Opisywany model wymaga pełnego obustronnego zaangażowania, otwartości w dyskusji oraz wspólnej, symultanicznej wymiany informacji. Taki sposób komunikacji poprawia zdrowie emocjonalne pacjenta, obniża poziom żalu przy niewłaściwej decyzji, pomaga utrzymać zalecany reżim leczenia, pozwala lepiej kontrolować ból i ma wpływ na ogólne wyniki leczenia. Zatem poprawa zaangażowania chorego w proces leczenia wydaje się zasadnicza. Tutaj, istotną rolę odgrywają firmy farmaceutyczne podejmujące działania w obszarze społecznej odpowiedzialności biznesu (CSR) w zakresie edukacji, badań naukowych i profilaktyki. Aktywności pro-pacjenckie są także nakierowane na umacniania świadomości i zaangażowania chorego, pozytywnie wpływają na kształtowanie poczucia odpowiedzialności, motywacji i pozytywnego nastawienia. W artykule przedstawiono, jak działania CSR kształtują wartość dla pacjenta i wspierają całościowo proces zmagania się z chorobą. Forum Reumatol. 2018, tom 4, nr 4: 231–23

External quality monitoring facilitates improvement in already well-performing stroke units: insights from RES-Q Poland

Introduction. The Registry of Stroke Care Quality (RES-Q) is used in Poland for quality monitoring by numerous hospitals participating in the Angels Initiative. Our aim was to assess the degree of improvement in highly stroke-oriented centres that report cases to the RES-Q each year. Material and methods. This retrospective analysis included Polish stroke units that from January 2017 to December 2020 contributed to the RES-Q at least 25 patients annually. Results. Seventeen out of 180 Polish stroke units reported patients each year (2017, n = 1,691; 2018, n = 2,986; 2019, n = 3,750; 2020, n = 3,975). The percentage of ischaemic stroke patients treated with alteplase remained stable (26%, 29%, 30% and 28%, respectively). The door-to-needle time progressively decreased, from a median 49 minutes to 32 minutes. The percentage of patients treated ≤ 60 minutes and ≤ 45 minutes significantly increased (from 68% to 86% and from 43% to 70%, respectively), with no change observed between 2019 and 2020. Despite a general improvement in dysphagia screening (81%, 91%, 98% and 99%), screening performed within the first 24h from admission became less frequent (78%, 76%, 69% and 65%). In-hospital mortality significantly increased (11%, 11%, 13% and 15%), while the proportion of patients discharged home remained stable. Conclusions. Quality-oriented projects facilitate the improvement of stroke care, even in centres demonstrating good baseline performance. Polish stroke units that consistently reported cases to the RES-Q demonstrated improvement in terms of door-to- -needle time and dysphagia screening. However, there is still a need to shorten the time to dysphagia screening, and carefully monitor stroke unit mortality following the COVID-19 pandemic